Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy.

A survival analysis based on the overall mortality did not correctly interpret the effect of chemotherapy. Adjuvant chemotherapy did not provide an additional benefit to patients with high-risk stage II or patients with stage III at high risk of non-cancer death.